Biomarin Pharmaceutical reported $494.65M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 168.21M 60.27M
Acorda Therapeutics ACOR:US $ 44.97M 5.73M
Agios Pharmaceuticals AGIO:US $ 100.52M 1.24M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Amgen AMGN:US $ 4.42B 680M
Bayer BAYN:GR 12.65B 2.22B
Biogen BIIB:US $ 2648.2M 727.1M
Biomarin Pharmaceutical BMRN:US $ 494.65M 112.61M
Bluebird Bio BLUE:US $ 108.92M 13.37M
Gilead Sciences GILD:US $ 4231M 2162M
Insmed INSM:US $ 153.54M 10.6M
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
IONIS PHARMACEUT IONS:US $ 219.3M 19.88M
Moderna Inc MRNA:US 2.3B 463M
Neurocrine Biosciences NBIX:US $ 393.5M 86M
Ptc Therapeutics PTCT:US $ 257.89M 22.63M
Puma Biotechnology PBYI:US $ 47.52M 1.01M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Sangamo Biosciences SGMO:US $ 75.11M 1.62M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Seattle Genetics SGEN:US $ 630.61M 71.1M
Ultragenyx Pharmaceutical RARE:US $ 230.94M 14.37M
United Therapeutics UTHR:US $ 265.1M 89.5M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
YTE INCY:US $ 656.97M 40.27M